Vasopressin in pediatric vasodilatory shock: A multicenter randomized controlled trial

American Journal of Respiratory and Critical Care Medicine

Volumn 180, Issue 7, 2009, Pages 632-639

  Choong, Karen ^a   Bohn, Desmond ^b   Fraser, Douglas D ^c   Gaboury, Isabelle ^d   Hutchison, James S ^b   Joffe, Ari R ^e   Litalien, Catherine ^f   Menon, Kusum ^d   McNamara, Patrick ^b   Ward, Roxanne E ^d  

^a MCMASTER CHILDREN S HOSPITAL   (Canada)

^b HOSPITAL FOR SICK CHILDREN   (Canada)

^c CHILDREN S HOSPITAL OF WESTERN ONTARIO   (Canada)

^d CHILDREN S HOSPITAL OF EASTERN ONTARIO   (Canada)

^e STOLLERY CHILDREN S HOSPITAL   (Canada)

^f UNIVERSITY OF MONTREAL   (Canada)

Author keywords

Pediatric; Shock; Vasopressin

Indexed keywords

ADRENALIN; ARGIPRESSIN; CORTICOSTEROID DERIVATIVE; DOPAMINE; HYDROCORTISONE; MILRINONE; NORADRENALIN; PLACEBO; VASOPRESSIN;

ADD ON THERAPY; ADOLESCENT; ADRENAL INSUFFICIENCY; ARTERY THROMBOSIS; ARTICLE; ARTIFICIAL VENTILATION; BRADYCARDIA; CANCER CHEMOTHERAPY; CHILD; CHILDHOOD DISEASE; CHILDHOOD MORTALITY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG SAFETY; FEMALE; FINGER ISCHEMIA; FULMINATING PURPURA; GASTROINTESTINAL HEMORRHAGE; HEART ARREST; HEMODYNAMICS; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYPOKALEMIA; HYPOTENSION; IMMUNOMODULATION; INTENSIVE CARE UNIT; ISCHEMIA; LENGTH OF STAY; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; MULTICENTER STUDY; MULTIPLE ORGAN FAILURE; OPEN STUDY; PRESCHOOL CHILD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY TRACT DISEASE; SCHOOL CHILD; SHOCK; THROMBOCYTOPENIA; TREATMENT OUTCOME; VASODILATORY SHOCK; VASOPRESSIN BLOOD LEVEL; VENTILATOR;

ADOLESCENT; ARGININE VASOPRESSIN; BLOOD PRESSURE; CHILD; CHILD, PRESCHOOL; DOUBLE-BLIND METHOD; FEMALE; HUMANS; LENGTH OF STAY; MALE; MULTIPLE ORGAN FAILURE; SHOCK; SURVIVAL ANALYSIS; TREATMENT OUTCOME; VASOCONSTRICTOR AGENTS;

EID: 70349464971     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.200902-0221OC     Document Type: Article

References (47)

1. Proulx F, Fayon M, Farrell CA, Lacroix J, Gauthier M. Epidemiology of sepsis and multiple organ dysfunction syndrome in children. Chest 1996;109:1033-1037. (Pubitemid 26113649)
2. Watson RS, Carcillo JA, Linde-Zwirble WT, Clermont G, Lidicker J, Angus DC. The epidemiology of severe sepsis in children in the United States. Am J Respir Crit Care Med 2003;167:695-701. (Pubitemid 36801744)
3. Leclerc F, Leteurtre S, Duhamel A, Grandbastien B, Proulx F, Martinot A, Gauvin F, Hubert P, Lacroix J. Cumulative influence of organ dysfunctions and septic state on mortality of critically ill children. Am J Respir Crit Care Med 2005;171:348-353. (Pubitemid 40223402)
4. Mullner M, Urbanek B, Havel C, Losert H, Waechter F, Gamper G. Vasopressors for shock. Cochrane Database Syst Rev 2004;CD003709.
5. Dellinger RP, Levy MM, Carlet JM, Bion J, Parker MM, Jaeschke R, Reinhart K, Angus DC, Brun-Buisson C, Beale R, et al.; for the International Surviving Sepsis Campaign Guidelines Committee. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock:2008. Crit Care Med 2008;36:286-327.
6. Farand P, Hamel M, Lauzier F, Plante GE, Lesur O. Review article: organ perfusion/permeability-related effects of norepinephrine and vasopressin in sepsis. Can J Anaesthia 2006;53:934-946. (Pubitemid 44710260)
7. McNamara PJ. Too much of a good thing? Epinephrine on trial! J Perinatol 2005;25:223-224. [Author reply 5].
8. Asfar P, Hauser B, Radermacher P, Matejovic M. Catecholamines and vasopressin during critical illness. Crit Care Clin 2006;22:131-149.
9. Choong K, Kissoon N. Vasopressin in pediatric shock and cardiac arrest. Pediatr Crit Care Med 2008;9:372-379.
10. Landry DW, Oliver JA. The pathogenesis of vasodilatory shock. N Engl J Med 2001;345:588-595.
11. Holmes CL, Landry DW, Granton JT. Science review: vasopressin and the cardiovascular system part 1-receptor physiology. Crit Care 2003;7:427-434.
12. Landry DW, Levin HR, Gallant EM, Ashton RC Jr, Seo S, D'Alessandro D, Oz MC, Oliver JA. Vasopressin deficiency contributes to the vasodilation of septic shock. Circulation 1997;95:1122-1125. (Pubitemid 27097820)
13. Jochberger S, Dörler J, Luckner G, Mayr VD, Wenzel V, Ulmer H, Morgenthaler NG, Hasibeder WR, Dünser MW. The vasopressin and copeptin response to infection, severe sepsis, and septic shock. Crit Care Med 2009;37:476-482.
14. Russell J. Vasopressin in vasodilatory and septic shock. Curr Opin Crit Care 2007;13:383-391.
15. Dünser MW, Mayr AJ, Ulmer H, Knotzer H, Sumann G, Pajk W, Friesenecker B, Hasibeder WR. Arginine vasopressin in advanced vasodilatory shock: a prospective, randomized, controlled study. Circulation 2003;107:2313-2319. (Pubitemid 36578501)
16. Patel BM, Chittock DR, Russell JA, Walley KR. Beneficial effects of short-term vasopressin infusion during severe septic shock. Anesthesiology 2002;96:576-582. (Pubitemid 34193495)
17. Meyer S, Gortner L, McGuire W, Baghai A, Gottschling S. Vasopressin in catecholamine-refractory shock in children. Anaesthesia 2008;63:228-234.
18. Ceneviva G, Paschall JA, Maffei F, Carcillo JA. Hemodynamic support in fluid-refractory pediatric septic shock. Pediatrics 1998;102:e19.
19. Carcillo JA, Pollack MM, Ruttimann UE, Fields AI. Sequential physiologic interactions in pediatric cardiogenic and septic shock. Crit Care Med 1989;17:12-16.
20. Pollack MM, Patel KM, Ruttimann UE. PRISM III: an updated Pediatric Risk of Mortality score. Crit Care Med 1996;24:743-752.
21. Marshall JC. Charting the course of critical illness: prognostication and outcome description in the intensive care unit. Crit Care Med 1999;27:676-678.
22. Leteurtre S, Martinot A, Duhamel A, Proulx F, Grandbastien B, Cotting J, Gottesman R, Joffe A, Pfenninger J, Hubert P, et al. Validation of the paediatric logistic organ dysfunction (PELOD) score: prospective, observational, multicentre study. Lancet 2003;362:192-197. (Pubitemid 36859934)
23. Bichet D, Arthus M, Barjon J, Lonergan M, Kortas C. Human platelet fraction arginine-vasopressin: potential physiological role. J Clin Invest 1987;79:881-887. (Pubitemid 17050916)
24. Wernovsky G, Wypij D, Jonas RA, Mayer JE Jr, Hanley FL, Hickey PR, Walsh AZ, Chang AC, Castañeda AR, Newburger JW, et al. Postoperative course and hemodynamic profile after the arterial switch operation in neonates and infants: a comparison of low-flow cardiopulmonary bypass and circulatory arrest. Circulation 1995;92:2226-2235.
25. Lakatos E, Lan KK. A comparison of sample size methods for the logrank statistic. Stat Med 1992;11:179-191.
26. Gray R. A class of k-sample test for comparing the cumulative incidence of a competing risk. Ann Statist 1988;16:1141-1154.
27. Fergusson D, Aaron SD, Guyatt G, Hébert P. Post-randomisation exclusions: the intention to treat principle and excluding patients from analysis. BMJ 2002;325:652-654.
28. Leone M, Boyle WA. Decreased vasopressin responsiveness in vasodilatory shock-like conditions. Crit Care Med 2006;34:1126-1130.
29. Luckner G, Mayer V, Jochberger S, Wenzel V, Ulmer H, Hasibeder WR, Dünser MW. Comparison of two dose regimens of arginine vasopressin in advanced vasodilatory shock. Crit Care Med 2007;35:2280-2285. (Pubitemid 47476224)
30. Holmes CL, Walley KR, Chittock DR, Lehman T, Russell JA. The effects of vasopressin on hemodynamics and renal function in severe septic shock: a case series. Intensive Care Med 2001;27:1416-1421. (Pubitemid 32758942)
31. Russell J, Walley K, Singer J, Gordon AC, Hébert PC, Cooper DJ, Holmes CL, Mehta S, Granton JT, Storms MM, et al.; VASST Investigators. Vasopressin versus norepinephrine infusion in patients with septic shock. N Engl J Med 2008;358:877-887.
32. Yildizdas D, Yapicioglu H, Celik U, Sertdemir Y, Alhan E. Terlipressin as a rescue therapy for catecholamine-resistant septic shock in children. Intensive Care Med 2008;34:511-517. (Pubitemid 351623035)
33. Ertmer C, Rehberg S, Westphal M. Vasopressin analogues in the treatment of shock states: potential pitfalls. Best Pract Res Clin Anaesthesiol 2008;22:393-406. (Pubitemid 351804046)
34. Parker MM. Pathophysiology of cardiovascular dysfunction in septic shock. New Horiz 1998;6:130-138. (Pubitemid 28283761)
35. Shawcross D, Davies N, Mookerjee R, Hayes PC, Williams R, Lee A, Jalan R. Worsening of cerebral hyperemia by the administration of terlipressin in acute liver failure with severe encephalopathy. Hepatology 2004;39:471-475. (Pubitemid 38222188)
36. Dubois MJ, De Backer D, Creteur J, Anane S, Vincent JL. Effect of vasopressin on sublingual microcirculation in a patient with distributive shock. Intensive Care Med 2003;29:1020-1023. (Pubitemid 36783180)
37. Asfar P, Radermacher P, Hauser B. Vasopressin and splanchnic blood flow: vasoconstriction does not equal vasoconstriction in every organ. Intensive Care Med 2006;32:21-23. (Pubitemid 43040080)
38. Dünser MW, Mayr AJ, Tür A, Pajk W, Barbara F, Knotzer H, Ulmer H, Hasibeder WR. Ischemic skin lesions as a complication of continuous vasopressin infusion in catecholamine-resistant vasodilatory shock: incidence and risk factors. Crit Care Med 2003;31:1394-1398. (Pubitemid 36583849)
39. Rodríguez-Núñez A, Fernández-Sanmartín M, Martinón-Torres F, González-Alonso N, Martinón- Sánchez JM. Terlipressin for catecholamine-resistant septic shock in children. Intensive Care Med 2004;30:477-480. (Pubitemid 38375625)
40. van Haren FM, Rozendaal FW, van der Hoeven JG. The effect of vasopressin on gastric perfusion in catecholamine-dependent patients in septic shock. Chest 2003;124:2256-2260. (Pubitemid 38010597)
41. Morgenthaler N, Struck J, Jochberger S, Dünser MW. Copeptin: clinical use of a new biomarker. Trends Endocrinol Metab 2008;19:43-49. (Pubitemid 351317895)
42. Nicholson C, Gans B, Chang A, Pollack MM, Blackman J, Giroir BP, Wilson D, Zimmerman JJ, Whyte J, Dalton HJ, et al. Pediatric critical care medicine: planning for our research future. Pediatr Crit Care Med 2003;4:196-202.
43. Wilson D, Dean J, Newth C, Pollack M, Anand KJ, Meert K, Carcillo J, Zimmerman J, Nicholson C. Collaborative Pediatric Critical Care Research Network (CPCCRN). Pediatr Crit Care Med 2006;7:301-307. (Pubitemid 44048271)
44. Carcillo JA, Fields AI. Clinical practice parameters for hemodynamic support of pediatric and neonatal patients in septic shock. Crit Care Med 2002;30:1365-1378. (Pubitemid 34620986)
45. Curley MA, Zimmerman JJ. Alternative outcome measures for pediatric clinical sepsis trials. Pediatr Crit Care Med 2005;6:S150-S156. (Pubitemid 40724269)
46. Goldstein B, Giroir B, Randolph A. International pediatric sepsis consensus conference: definitions for sepsis and organ dysfunction in pediatrics. Pediatr Crit Care Med 2005;6:2-8. (Pubitemid 40956461)
47. Brierley J, Carcillo J, Choong K, Cornell T, Decaen A, Deymann A, Doctor A, Davis A, Duff J, Dugas MA, et al. Clinical practice parameters for hemodynamic support of pediatric and neonatal septic shock: 2007 update from the American College of Critical Care Medicine. Crit Care Med 2009;37:666-688.